Advanced Pharma Recalls Lorazepam HCl Due to Latex Labeling
Advanced Pharma Inc. is recalling all lots of Lorazepam HCl because the product may contain synthetic or natural latex, which is not currently labeled.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a labeling error regarding latex content, which is a moderate risk for allergic individuals but does not involve reported deaths or serious injuries in the source text.
Plain-English summary
Advanced Pharma Inc. has initiated a recall of Lorazepam HCl in all strengths, dosage forms, and packaging. The recall is limited to products distributed nationwide in the United States. The specific reason for the recall is a labeling issue where the products may contain synthetic latex and/or natural latex, but this information is not currently classified or labeled on the packaging.
This recall affects all lots of the medication. The product is a prescription-only medication manufactured by Advanced Pharma Inc. and distributed by Avella of Houston in Houston, Texas. The hazard is identified as a labeling deficiency regarding the presence of latex, which is a known allergen for some individuals.
Consumers and healthcare providers should check their inventory for Lorazepam HCl products from Advanced Pharma Inc. If the product is found, it should be returned to the pharmacy or point of purchase. Patients who are allergic to latex should consult their healthcare provider regarding alternative medications or precautions.
The recalled product
- Product
- Lorazepam HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
- Manufacturer
- Advanced Pharma Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 60 recalled by Advanced Pharma Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 60 products in this recall →Related recalls
Same manufacturer · Advanced Pharma Inc.
See all →- HighAdvanced Pharma Recalls Sub-Potent Hydromorphone Injectable Solution
FDA (Drugs) · 2019-05-08
- SevereAdvanced Pharma Recalls Lidocaine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- HighAdvanced Pharma Recalls Glycopyrrolate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Heparin Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Phenylephrine HCl Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
Same hazard · latex allergen
See all →- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateHalyard Total Joint Kits Recalled for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits Due to Latex Labeling Error
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOASIS MRI table pads recalled for missing latex allergen labeling
FDA (Devices) · 2021-09-01